Archives

by in
Entry Author Date Location
With $22M, True North Points Toward Rare-Disease Clinical Trials 06/17/14 San Francisco
Seeking Tau: BMS Buys iPierian and Brain-Disease Program for $175M 04/29/14 San Francisco
iPierian Nabs $30M To Keep Alzheimer’s, Autoimmune Drugs Moving 09/04/13 San Francisco
Translating Nobel Science Into Novel Drugs 10/12/12 San Francisco
iPierian Zeroes In on Antibodies for Alzheimer’s, Neurodegeneration 05/21/12 San Francisco
CytomX Therapeutics Seeks to One-Up Lilly, Amgen Cancer Drugs 03/02/12 San Francisco
Ipierian Hires New CEO to Carry on With Stem Cells for Discovering Neurological Drugs 09/07/11 San Francisco
FivePrime Nabs Partner, Solazyme’s $100M IPO Plan, Where Blockbuster Drugs Come From, & More Bay Area Life Sciences News 03/18/11 San Francisco
Will the Bay Area Still Be the No. 1 Biotech Cluster in 20 Years? We’ll Ask Tomorrow 03/15/11 San Francisco
Will the Bay Area Lose Its Edge as the Top Biotech Hub in 20 Years? We’ll Ask March 16 03/03/11 San Francisco
What Will the Bay Area Biotech Hub Look Like in 20 Years? Xconomy Event To Take the Long View on March 16 02/02/11 San Francisco
Cytomx, Backed by Third Rock & Roche, Raises $30M for New Class of Antibodies 09/23/10 San Francisco
Page 1 of 1